We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Gregory Schwartz

Gregory G. Schwartz MD, PhD

Professor of Medicine, University of Colorado School of Medicine, Aurora, Colorado

Gregory G. Schwartz, MD, PhD, is Professor of Medicine (Division of Cardiology) at the University of Colorado. He is also Chief of Cardiology at the Rocky Mountain Regional VA Medical Center in Aurora, Colorado (USA).

Dr. Schwartz graduated from Brown University in Providence, RI with a degree in Biomedical Engineering, and then received PhD and MD degrees from Duke University in Durham, NC. He completed residency in Internal Medicine at the University of Colorado and fellowship in Cardiology at the University of California San Francisco (UCSF), where he served on the faculty as Assistant and Associate Professor before assuming his present position.

Dr. Schwartz’ clinical research has focused on trials of lipid and metabolic interventions in coronary heart disease, including the placebo-controlled cardiovascular outcomes trials that established the efficacy of intensive statin treatment (MIRACL, 2001) and PCSK9 inhibition (ODYSSEY OUTCOMES, 2018) after acute coronary syndrome. Among current activities, Dr. Schwartz is Chair of the VA Cooperative Study “VA-IMPACT” testing the cardiovascular efficacy of metformin in pre-diabetes. In basic research, Dr. Schwartz directs a swine physiology laboratory that investigates translational questions in myocardial energy metabolism and ischemic protection.